A phase II trial of adjuvant low-dose total body irradiation in non-hodgkin's lymphoma patients following standard CHOP

By Safwat Akmal   Bayoumi Yasser   Akkoush Hany   Mahmoud Hossam  

Acta Oncologica, Vol. 43, Iss. 5, 2004-07 ,pp. : 480-485

Informa Healthcare

Access to resources Recommend Favorite

Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

By Mey Ulrich   Orlopp Katjana   Flieger Dimitri   Strehl John   Ho Anthony   Hensel Manfred   Bopp Cordula   Gorschlüter Marcus   Wilhelm Martin   Birkmann Josef   Kaiser Ulrich   Neubauer Andreas   Florschütz Axel   Rabe Christian   Hahn Corinna   Glasmacher Axel   Schmidt-Wolf Ingo  

Cancer Investigation, Vol. 24, Iss. 6, 2006-09 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

The potential palliative role and possible immune modulatory effects of low-dose total body irradiation in relapsed or chemo-resistant non-Hodgkin's lymphoma

By Safwat A.   Bayoumy Y.   El-Sharkawy N.   Shaaban K.   Mansour O.   Kamel A.  

Radiotherapy and Oncology, Vol. 69, Iss. 1, 2003-10 ,pp. : 33-36

Elsevier

Access to resources Recommend Favorite

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer

By Hirose Takashi   Shirai Takao   Ishida Hiroo   Ando Kohichi   Sugiyama Tomohide   Kusumoto Sojiro   Hosaka Takamichi   Nakashima Masanao   Ohmori Tohru   Adachi Mitsuru  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 267-274

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

By Kallab Andre   Nalamolu Yasolatha   Dainer Paul   Jillella Anand  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 145-151

Humana Press, Inc

Access to resources Recommend Favorite